Dr. Daniela Romero Crousillat, MD

Dr. Crousillat practices at USFCenter for Advanced Healthcare in Tampa, Florida.

Dr. Crousillat's NPI, 1518305085, was assigned on June 6, 2013. Dr. Crousillat graduated from New York University School of Medicine in 2013. Dr. Crousillat holds Florida license ME148687.

Dr. Crousillat's primary practice is USFCenter for Advanced Healthcare, at 13330 Usf Laurel Dr, Tampa, FL 33612 in Hillsborough County. The practice phone is (813) 974-2201.

Dr. Crousillat's primary practice is USFCenter for Advanced Healthcare in Tampa, Florida. Dr. Crousillat is also affiliated with Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Crousillat to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crousillat practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Crousillat's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Crousillat is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Crousillat's licenses on file in 2 states: Florida and Massachusetts.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, chronic embolism thrombosis, chronic hypertension, coronary artery disease, deep vein thrombosis (DVT) and heart failure among the conditions Dr. Crousillat treats.

CMS data shows 931 Medicare services from Dr. Crousillat across 15 procedure codes in 2024, for 707 Medicare patients. Medicare paid $67,814 for them.

CMS counts 707 Medicare patients who saw Dr. Crousillat in 2024. The largest group is 65 to 74, with 280 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Crousillat's median patient age at 67, with 55% women.

In 2024, Dr. Crousillat wrote 993 Medicare Part D claims for 136 patients. 75% of them were for generic drugs. CMS names the drug for 900 of them, across 24 drugs with 11 or more claims each, at $248,500 in total drug cost. In 2023, CMS named 561 claims across 18 drugs.

Dr. Crousillat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Crousillat as offering telehealth.

Dmand AI links 33 papers to Dr. Crousillat, published from 2018 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Aortic Valve Stenosis, Echocardiography and Pregnancy Complications, Cardiovascular. Dr. Crousillat has published most often in JACC Adv. Dr. Crousillat's most frequent co-authors are Nandita S. Scott, MD, Malissa J. Wood, MD and Mary A. Cain, MD.

Dmand AI links Dr. Crousillat to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Coronary Artery Dissection, Spontaneous and Death, Sudden, Cardiac.

CMS Open Payments shows 14 general payments to Dr. Crousillat from 7 drug and device companies from 2022 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. HeartFlow, Inc. paid the most, $5,500.

Dr. Crousillat graduated from New York University School of Medicine in 2013.

Dr. Crousillat is in network with 19 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.